Oasmia Pharmaceutical AB (NASDAQ:OASM)

1.39
Delayed Data
As of 2:58pm ET
 -0.0431 / -3.01%
Today’s Change
0.80
Today|||52-Week Range
3.16
+57.94%
Year-to-Date
No recent news for Oasmia Pharmaceutical AB.

Today’s Trading

Previous close1.43
Today’s open1.39
Day’s range1.38 - 1.40
Volume11,467
Average volume (3 months)29,515
Market cap$84.3M
Data as of 2:58pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+1.82%
Earnings growth (this year)+58.59%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.41%
P/E ratioNM
Price/Sales4,136.78
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...+0.15+4.45%
BGNEBeiGene Ltd+5.98+3.99%
TEVATeva Pharmaceutical-0.29-1.44%
Data as of 4:00pm ET, 02/22/2018

Financials

Next reporting dateMarch 2, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$19.6K
Annual profit (last year)-$18.3M
Net profit margin-93,164.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Mikael Asp
Chief Financial Officer &
Executive Vice President
Anders Blom
Corporate headquarters
Uppsala, Uppsala

Forecasts